SBRA - Sabra Health Care R... Stock Analysis | Stock Taper
Logo
Sabra Health Care REIT, Inc.

SBRA

Sabra Health Care REIT, Inc. NASDAQ
$20.55 -1.49% (-0.31)

Market Cap $5.18 B
52w High $21.07
52w Low $15.75
Dividend Yield 6.46%
Frequency Quarterly
P/E 32.11
Volume 4.32M
Outstanding Shares 252.15M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $211.9M $66.91M $27.23M 12.85% $0.11 $107.98M
Q3-2025 $190.04M $60.83M $22.54M 11.86% $0.09 $100.36M
Q2-2025 $189.15M $56.1M $65.54M 34.65% $0.28 $137.17M
Q1-2025 $183.54M $56.22M $40.3M 21.96% $0.17 $111.31M
Q4-2024 $182.35M $55.22M $46.7M 25.61% $0.2 $125.19M

What's going well?

Revenue is up sharply, and profits are growing even faster. The company is keeping expenses in check, and earnings per share are rising.

What's concerning?

Gross margins slipped a bit, and interest costs remain a big drag on profits. Share dilution means each share represents a slightly smaller piece of the company.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $71.54M $5.49B $2.67B $2.82B
Q3-2025 $200.6M $5.56B $2.74B $2.82B
Q2-2025 $95.17M $5.33B $2.62B $2.71B
Q1-2025 $22.65M $5.23B $2.53B $2.7B
Q4-2024 $60.47M $5.3B $2.56B $2.74B

What's financially strong about this company?

The company has solid asset quality with almost no goodwill, and it reduced its debt load significantly this quarter. Equity remains strong, and there are no hidden liabilities.

What are the financial risks or weaknesses?

Liquidity is in crisis—current assets cover only a fraction of near-term bills, and cash reserves are low. Negative retained earnings show a history of losses, and working capital is under pressure.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $27.23M $87.43M $-116.55M $-100.89M $-129.38M $87.43M
Q3-2025 $22.52M $99.96M $-199.84M $206.17M $105.87M $99.96M
Q2-2025 $65.54M $80.96M $-45.13M $36.73M $72.75M $80.96M
Q1-2025 $40.3M $80.26M $-16.44M $-101.24M $-37.44M $80.26M
Q4-2024 $46.7M $79.97M $18.56M $-100.96M $-2.64M $79.97M

What's strong about this company's cash flow?

The company generates steady cash from its core business, easily covering dividends. It is reducing debt and still producing more cash than reported profits, showing high-quality earnings.

What are the cash flow concerns?

Cash flow from operations is declining, and the company had a big drop in cash this quarter. Ongoing need to issue new shares and the lack of capital investment may not be sustainable long-term.

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Health Care Resident Service Ancillary Service
Health Care Resident Service Ancillary Service
$0 $0 $0 $0

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Sabra Health Care REIT, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Sabra shows a clear financial and operational turnaround, with rising revenue, much-improved profitability, and strong, steady cash flow that comfortably supports dividends. Its portfolio is diversified across essential healthcare and senior living segments that benefit from long-term demographic demand. Management brings deep operator experience, which underpins strong tenant relationships and a more hands-on SHOP strategy, while practical innovation in technology and sustainability enhances property performance and competitive positioning.

! Risks

Key concerns center on the balance sheet and operating leverage: liquidity ratios have weakened sharply as short-term debt and other current liabilities have surged, raising refinancing and near-term funding risk. Retained earnings have historically been negative and were reset through capital actions rather than built steadily through profits. Overhead costs are rising faster than revenue, and capital expenditures are very low, potentially limiting organic growth in the asset base. The business also faces external risks from healthcare regulation, reimbursement changes, labor pressures, and interest rate movements.

Outlook

The overall picture points to a company with improving earnings power and strong cash generation, operating in a sector with favorable long-term demand drivers but meaningful structural and financial risks. Future performance will likely hinge on how well Sabra manages its debt structure and liquidity, executes on expanding and optimizing its SHOP and behavioral health platforms, and continues to validate the returns from its technology and sustainability initiatives. If these elements are balanced carefully, Sabra could sustain its recent momentum, but its reliance on capital markets and the complexity of the healthcare ecosystem remain important constraints and watchpoints.